PolyTherics Ltd., a London-based company that modifies existing drugs to improve their efficacy, has raised Gbp2.3 million in new VC funding. Longbow Capital led the deal, and was joined by The Capital Fund and Imperial Innovations. www.polytherics.co.uk
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.